Software B BioPharm International
Q&A: Who Is Accountable When AI Gets Drug Development Wrong?
Matt Truppo, Richard Jaenisch, and Brian Drapeau examine AI's impact on drug success, human oversight, data governance, and biopharma's future.
Software headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Software B BioPharm International
Matt Truppo, Richard Jaenisch, and Brian Drapeau examine AI's impact on drug success, human oversight, data governance, and biopharma's future.
Software
MedTech Dive
The planned acquisition comes as wearable firms push to up their healthcare offerings.
Software B BioTechniques
In this edition of the biotech bi-weekly, learn more about the world’s first AI biosecurity lab launching in the UK, a versatile gel imaging system for proteomic, genomic and transcriptomic imaging, and a suite of new media for EVs. We also cover the latest funding rounds cleared…
Software S Scaling Biotech
In my last post, I argued that most of the impact from natural language LLM-based agents on drug discovery wouldn’t come from advanced reasoning applications like hypothesis generation, but rather from mundane technical tasks like reformatting plate maps.
Software B BLOPIG
Hey, Claude, which antibody has the most structures in SAbDab2? Show me every one of them, and what it's bound to. 24 selected GPCR complexes (of 552), coloured by family, superposed on the single scFv16 (blue) that holds their G protein (grey) in place. Find every antibody in SA…
Software M MetaphysicalCells
Welcome back to another edition of MetaphysicalCellsThis Substack is reader-supported.
Software W Weekly Tech+Bio
ALSO: argenx pays $550M upfront for AI-designed oral macrocycles; Third Rock signs an up-to-$2.16B AI antibody pact with China's Funnel Bio; AI agents run 11,000 wet-lab steps, and more...
Software
Ground Truths
A recording from Eric Topol's live video with annotations below
Software
Decoding Bio
Intro Formation Bio announced a new fund with $600M in capital commitments for in-licensing medicines and funding clinical development. Today, through conversation with Formation Bio’s CSO and Head of R&D, we unpack what this means for the company and how it fits into the fie…
Software P Pharmaceutical Executive
Experts consider what happens when artificial intelligence (A) tools multiply faster than organizations can connect them.
Software P Pharmaceutical Executive
Zoe Lazarra, Claudia Ciciliano, and Shankar Narayanan assess where artificial intelligence (AI) is already proving its value in pharma commercialization and where to go next.
Software M Mac in Chem
Another example of vibe-coded chemistry software. We present VIBE-QC, a general-purpose open-source electronic-structure code for molecules and solids, developed almost entirely through generative-AI-assisted programming (“vibe-coding”)
Software P Pharmaceutical Executive
A group of experts explore the advantages of purpose-built artificial intelligence (AI) for healthcare over generic models.
Software B BLOPIG
For the past few months, I’ve been working on an AI agent for antibody optimisation. The idea is to let the agent use existing computational tools to identify developability issues, suggest modifications, and evaluate the resulting candidates. Evaluating such an agent might sound…
Software P Paired Ends
If you don’t hit a guardrail Fable 5.2 is impressive.
Software A Applied Clinical Trials
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
Software S Science News
Several efforts aim to make torrent of AI testing results easier to understand and use
Software A Applied Clinical Trials
AI can draft a CSR in minutes, but the report only reflects evidence that has already converged, so faster drafting shifts the bottleneck to upstream reconciliation, database-lock readiness, and human accountability rather than shortening the trial itself.
Software M Mac in Chem
iChemLabs have just announced a version 8 of ChemDoodle 3D software. This update is free for all ChemDoodle subscriptions, Lifetime and Site licenses. Licenses are
Software
Inside Precision Medicine
Aaron Bossler, MD, PhD, explains how disruptive technologies and clinical implementation barriers shape patient care priorities for the Association of Molecular Pathology (AMP). The post AMP President: AI, Regulation, and Labor Shortages Threaten Molecular Diagnostics appeared fi…
Software L Latch Bio
We utilized 91 analytical tasks built from 43 neuroscience publications to benchmark 34 AI agent configurations, and found the best pass no more than 32% of the time.
Software M Mac in Chem
I recently published two Compound Lookup extensions for Safari and Chrome both of which have been downloaded over 100 times. They allow you so select
Software O Omics! Omics!
After some detours into other areas, I'm back to writing up my ASHG notes from a few weeks ago. I've encountered the Myra liquid handler at meetings going back to last year's ESHG in Milan, and have considered writing it up each time. That cycle has been made more pai…
Software
GEN
Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field heats up. The post New AI Models Are Turbo-Charging Protein Design appeared first on GEN - Genetic Engineering and Biotechnology News.
Software S Science News
New findings demonstrate AI’s aptitude for identifying technical flaws in studies where medical decisions are on the line
Software
Pharmaceutical Technology
Network Bio has entered into a research collaboration with Duke University to develop AI models of human disease using biospecimens and clinical records.
Software S Science News
Brain organoids offer highly efficient processing—if researchers can learn how to harness their power
Software M MetaphysicalCells
Welcome back to another edition of MetaphysicalCells this time on India’s TechBio/AI Drug Discovery sector.
Software N Nature Medicine
Software P Paired Ends
Mine is a very simple static site with markdown + pandoc. Here’s how.
Software I Is life worth living?
Almost 20 years ago, the Shoichet group introduced the Similarity Ensemble Approach (SEA), which predicts biological relationships based on chemical similarity. The original paper is openly available, and the link is below.https://pubmed.ncbi.nlm.nih.gov/17287757 This approach is…
Software
STAT Biotech
Once again, a hot new technology that was supposed to speed up drug research has fallen flat.
Software T The Niche
As long as I’ve been doing The Niche, I’ve been looking out for a possible truly promising new Huntington’s treatment. My focus has mainly been on the cell and gene therapy space. Now, we have groundbreaking news of FDA acceptance of a BLA for an investigational Hungtington’s gen…
Software P Pharmafile
Five UK research hubs are to receive more than £52m in government funding to develop technologies aimed at detecting disease earlier and supporting people to manage their health outside hospital. The hubs, based in Exeter, London, Southampton and Sunderland, will work on projects…
Software P Pharmaceutical Executive
Pharma leaders on why AI safety must be designed in from the start—and why human oversight is non-negotiable when patients are affected.
Software L Latch Bio
We gave models 35 challenging rare disease cases where they have to request what data they needed
Software W Weekly Tech+Bio
We have started this tracker to regularly update the community about where the progress goes with virtual cells and companies focusing on this paradigm.
Software
Fierce Pharma
Agentic AI Is Rewriting The Pharma Marketing Playbook scox Fri, 11/06/2026 - 12:43
Software S SecureBio
A SecureBio and RAND analysis of participant transcripts from the 2025 Active Site wet-lab uplift study finds that LLMs frequently gave incorrect advice, suggesting tacit knowledge was not the only barrier to novice uplift.